Skip to content
The Policy VaultThe Policy Vault

Votrient (pazopanib tablets) — Cigna

Bone Cancer

Initial criteria

  • Patient age ≥ 18 years
  • Patient has chondrosarcoma
  • Patient has metastatic disease AND widespread disease per prescriber

Approval duration

1 year